Gastrointestinal Pathogen Testing Market Outlook 2024-2033: Trends and Projections

Market Size – The gastrointestinal pathogen testing market size has grown steadily in recent years. It will grow from $3.89 billion in 2023 to $4.05 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth in the historic period can be attributed to the increased prevalence of gastrointestinal infections, growth in awareness about foodborne illnesses, globalization leading to higher travel-related infections, regulatory initiatives for food safety, rise in healthcare expenditure, and heightened demand for rapid and accurate diagnostic solutions.

The gastrointestinal pathogen testing market size is expected to see steady growth in the next few years. It will grow to $4.80 billion in 2028 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to the increasing prevalence of gastrointestinal infections globally, growing awareness about the importance of early detection and treatment, expanding healthcare infrastructure in emerging economies, rising demand for point-of-care testing solutions, heightened focus on food safety regulations, and continuous research and development efforts. Major trends in the forecast period include rapid testing methods, growing adoption of molecular diagnostic techniques, expansion of point-of-care testing in non-traditional healthcare settings, advancements in automation and robotics for streamlined testing processes, the emergence of novel biomarkers for enhanced pathogen detection, and integration of artificial intelligence and machine learning algorithms.

Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/gastrointestinal-pathogen-testing-global-market-report

Scope Of Gastrointestinal Pathogen Testing MarketThe Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Gastrointestinal Pathogen Testing Market Overview

Market Drivers –The rising incidences of foodborne disease are expected to propel the growth of the gastrointestinal pathogen testing market going forward. Foodborne diseases are illnesses caused by consuming food or beverages contaminated with pathogenic microorganisms, toxins, or chemical substances. Foodborne diseases include listeriosis, viral gastroenteritis, taeniasis, and trichinosis. The rise in foodborne incidents is due to various factors, including changes in food production, distribution, and consumption patterns, inadequate food safety measures, and climate change impacts on food production. Gastrointestinal testing helps in identifying the specific pathogens responsible for foodborne illnesses to help healthcare providers identify the cause of gastrointestinal symptoms, determine appropriate treatment, track outbreaks, and implement preventive measures to reduce the spread of foodborne diseases. For instance, in February 2024, according to the UK Health Security Agency, a UK-based government body, England and Wales reported 167 cases of listeriosis in 2022, compared to 160 cases in 2021. Therefore, the rising incidences of foodborne diseases are driving the growth of the gastrointestinal pathogen testing market.

Market Trends – Major companies operating in the gastrointestinal pathogen testing market are focusing on developing advanced solutions, such as metagenomic diagnostic tests, to enhance the accuracy, speed, and comprehensiveness of detecting gastrointestinal pathogens. A metagenomic diagnostic test is an advanced technology used to analyze the genetic material of microorganisms present in a sample, such as stool or blood. For instance, in April 2024, Microba Life Sciences, an Australia-based biotechnology company, introduced MetaPanel, a metagenomic diagnostic test designed to identify a wide range of gastrointestinal pathogens with unparalleled accuracy. MetaPanel covers 175 pathogen targets in a single test, offering healthcare professionals a comprehensive solution for diagnosing both common and hard-to-detect infections. It uses next-generation sequencing (NGS) technology to analyze a broad range of genetic material in a stool sample. This allows for the detection of a wide variety of potential pathogens, including those not routinely tested for in traditional GI (gastrointestinal) panels.

The gastrointestinal pathogen testing market covered in this report is segmented –

1) By Pathogen Type: Bacteria, Viruses, Parasites
2) By Test Type: Molecular Tests, Culture, Biochemical Tests, Other Test Types
3) By Panel Type: Syndromic Full Multiplex Panels, Other Panel Types
4) By End-User: Hospitals, Diagnostic Laboratories, Point-Of-Care, Other End Users

Get an inside scoop of the gastrointestinal pathogen testing market, Request now for Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15571&type=smp

Regional Insights – North America was the largest region in the gastrointestinal pathogen testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal pathogen testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies – Major companies operating in the gastrointestinal pathogen testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, Becton Dickinson and Company, Hologic Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., DiaSorin S.p.A., Cepheid Inc., OraSure Technologies Inc., BioFire Diagnostics Inc., Luminex Corporation, Meridian Bioscience Inc., Sekisui Diagnostics LLC, ELITechGroup S.A.S., Hardy Diagnostics LLC, Trinity Biotech plc, Puritan Medical Products Co. LLC, Cosmo Bio Co. Ltd., R-Biopharm AG, COPAN Diagnostics Inc., Savyon Diagnostics Ltd., ZeptoMetrix Corporation, Biomerica Inc., Pro-Lab Diagnostics

Table of Contents 1. Executive Summary2. Gastrointestinal Pathogen Testing Market Report Structure3. Gastrointestinal Pathogen Testing Market Trends And Strategies4. Gastrointestinal Pathogen Testing Market – Macro Economic Scenario5. Gastrointestinal Pathogen Testing Market Size And Growth…..27. Gastrointestinal Pathogen Testing Market Competitor Landscape And Company Profiles28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model